Lupin Receives US FDA Approval For Amlodipine Capsules (08-Feb-2010)
Pharma major, Lupin Ltd announced today that the US Food and Drug Administration (US FDA) has granted final approval for its Amlodipine/Benazepril 2,5mg/10mg, 5mg/10mg, 5mg/20ing and 10nig/2()mg capsules. Commercial shipments of the product have already commenced.
Lupin''s Amlodipine/Benazepril capsules are the AB-rated generic equivalent of Novartis'' I/jtrel® capsules indicated for the treatment of hypertension. Amlodipine/Benazcpril had annual sales of approximately $1.1 billion for the twelve months ended September 2009, based on IMS Health sales data.
Commenting on the approval, Nflesh Gupta, Group President and Executive DirecLor of Lupin Limited, said, "We are very pleased with the approval of our Amlodipine/Benazepril capsules, ITiis is a significant approval and it broadens our growing portfolio of cardiovascular medications with a strong complement to our existing product line." Mr, Gupta added, "The approval reflects the confidence and acceptance of our facility by die FDA, as well as our unwavering commitment to quality'' and to bringing important products to market."
Top News Today
 With a perspective to setup engine manufacturing plant in Karnataka, TVS Motors and the government officials in Karnataka would hold preliminary discussions on the possibility of setting up an engine manufacturing
 GM India vice-president P. Balendran stated that General Motors India will launch its electric car by October 2010.
It will be the battery-operated version of Spark which is the company''s mini car
 Air India is eyeing to introduce new flights from 28 March 2010, also it is planning to increase the frequency of flights on various sectors from the same period.
Mr. Praful Patel, Civil Aviation Minster
|
Live Market Discussions With Site Visitors
|
|
|